1.Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
Tamaki TANAKA ; Kazuhiro TAKEHARA ; Natsumi YAMASHITA ; Mika OKAZAWA-SAKAI ; Kazuya KURAOKA ; Norihiro TERAMOTO ; Kenichi TAGUCHI ; Katsushige YAMASHIRO ; Hidenori KATO ; Tomoya MIZUNOE ; Rie SUZUKI ; Dan YAMAMOTO ; Arisa UEKI ; Toshiaki SAITO
Journal of Gynecologic Oncology 2022;33(5):e67-
Objective:
To clarify the frequency of deficient mismatch repair (dMMR) in Japanese ovarian cancer patients, we examined microsatellite instability (MSI) status and immunohistochemistry (IHC) subtypes, including endometrioid carcinoma (EMC), clear cell carcinoma (CCC), or a mixture of both (Mix).
Methods:
We registered 390 patients who were diagnosed with EMC/CCC/Mix between 2006 and 2015 and treated at seven participating facilities. For 339 patients confirmed eligible by the Central Pathological Review Board, MSI, IHC, and MutL homolog 1 methylation analyses were conducted. The tissues of patients with Lynch syndrome (LS)-related cancer histories, such as colorectal and endometrial cancer, were also investigated.
Results:
MSI-high (MSI-H) status was observed in 2/217 CCC (0.9%), 10/115 EMC (8.7%), and 1/4 Mix (25%). Additionally, loss of MMR protein expression (LoE-MMR) was observed in 5/219 (2.3%), 16/115 (14.0%), and 1/4 (25%) patients with CCC, EMC, and Mix, respectively. Both MSI-H and LoE-MMR were found significantly more often in EMC (p<0.001). The median (range) ages of patients with MMR expression and LoE-MMR were 54 (30–90) and 46 (22–76) (p=0.002), respectively. In the multivariate analysis, advanced stage and histological type were identified as prognostic factors.
Conclusion
The dMMR rate for EMC/CCC was similar to that reported in Western countries. In Japan, it is assumed that the dMMR frequency is higher because of the increased proportion of CCC.
Result Analysis
Print
Save
E-mail